News and innovation February 12, 2024
Best practices for phase 1 investigational drugs trials
Before pharmaceutical products are released onto the market, they undergo extensive screening as an investigational drug (IND, or investigational new…
Best practices for phase 1 investigational drugs trials
Before pharmaceutical products are released onto the market, they undergo extensive screening as an investigational drug (IND, or investigational new…
Key insights on recent amendments to EU-MDR
The European Medical Device Regulation (EU-MDR) 2017/745 has brought many changes to the medical device industry and product availability. Thanks…
PICC line or port catheter: Which one for cancer patients?
It can be challenging knowing when to insert a peripherally inserted central catheter (PICC line) or port catheter into patients…
Quality control of prefilled flush syringes: key considerations
Before delving into the quality control of prefilled flush syringes, which are an integral part of vascular access management (VAM),…
Antibiotics shortages in Europe: what you need to know
“A new approach is needed to better tackle medicines shortages in the European Health Union,” the European Commission said in…
Safe connections webinar: open vs closed IV access
How can we define safe connections? Connections are critical junctures and/or points of access along intravenous (IV) lines. Microorganisms may…